| abstract |
The invention relates to a clinical panel, a microarray (e.g., a DNA chip), and a method, for determining a causative agent of human disease, more particularly, infectious disease and mitochondrial disorders. The clinical panel of the invention contains at least one pair of oligonucleotides (reverse primers, forward primers), whereby both oligonucleotides of the pair are suitable for use as primers for the amplification by means of polymerase chain reaction of one or both complementary strands of a DNA segment of a human infectious agent or human mitochondria DNA containing a mutation. |